We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

47 hedge funds and large institutions have $11.8M invested in Acorda Therapeutics in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 15 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more call options, than puts

Call options by funds: $226K | Put options by funds: $102K

19% more capital invested

Capital invested by funds: $9.86M → $11.8M (+$1.92M)

22% less funds holding

Funds holding: 60 → 47 (-13)

47% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 15

59% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 22

Holders
47
Holders Change
-13
Holders Change %
-21.67%
% of All Funds
0.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
8
Reduced
15
Closed
22
Calls
$226K
Puts
$102K
Net Calls
+$124K
Net Calls Change
+$814K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$190K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$166K
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$149K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$114K
5
Group One Trading
Group One Trading
Illinois
+$90.5K

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$840K
2
Parallax Volatility Advisers
Parallax Volatility Advisers
California
-$829K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$799K
4
GCP
GSA Capital Partners
United Kingdom
-$346K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$222K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
26
Salzhauer Michael
$18K – – –
Bank of New York Mellon
27
Bank of New York Mellon
New York
$17K – – –
Ohio Public Employees Retirement System (OPERS)
28
Ohio Public Employees Retirement System (OPERS)
Ohio
$17K – – –
QI
29
QS Investors
New York
$15K – – –
UBS Group
30
UBS Group
Switzerland
$12K -$32.5K -354 -72%
Charles Schwab
31
Charles Schwab
California
$11K – – –
BCM
32
Bayesian Capital Management
New York
$10K +$11.1K +121 New
RA
33
Royce & Associates
New York
$9K -$4.05K -44 -29%
Morgan Stanley
34
Morgan Stanley
New York
$9K -$919 -10 -8%
BMC
35
Benin Management Corp
Connecticut
$9K +$736 +8 +8%
CL
36
CSS LLC
Illinois
$8K – – –
GF
37
Gabelli Funds
New York
$7K – – –
SDIC
38
South Dakota Investment Council
South Dakota
$4K – – –
NC
39
NewSquare Capital
Pennsylvania
$2K – – –
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
$1K -$8.09K -88 -87%
Bank of America
41
Bank of America
North Carolina
$1K -$552 -6 -40%
Osaic Holdings
42
Osaic Holdings
Arizona
$1K -$92 -1 -6%
Citigroup
43
Citigroup
New York
$1K – – –
Parallax Volatility Advisers
44
Parallax Volatility Advisers
California
– -$829K -13,421 Closed
GCP
45
GSA Capital Partners
United Kingdom
– -$346K -5,601 Closed
Dimensional Fund Advisors
46
Dimensional Fund Advisors
Texas
– -$222K -3,595 Closed
Arrowstreet Capital
47
Arrowstreet Capital
Massachusetts
– -$148K -2,388 Closed
T. Rowe Price Associates
48
T. Rowe Price Associates
Maryland
– -$137K -2,219 Closed
William Blair & Company
49
William Blair & Company
Illinois
– -$74K -1,192 Closed
Citadel Advisors
50
Citadel Advisors
Florida
– -$102K -1,106 Closed
1
2
3

ACOR Hedge Fund Activity: Q4 2020 in Review

47 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q4 2020, worth a combined $11.8M — up 19% from $9.86M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of ACOR and 9 opened new positions — a net loss of 13 holders — while 15 trimmed existing stakes and 8 added.

The largest buyer was Renaissance Technologies, adding an estimated $190K. The largest seller was Point72 Asset Management, cutting an estimated $840K.

  • 47 institutional investors held Acorda Therapeutics (ACOR) as of Q4 2020, down from 60 in Q3 2020.
  • Funds reported $11.8M of Acorda Therapeutics stock for Q4 2020, up 19% quarter-over-quarter.
  • 9 funds opened new Acorda Therapeutics positions in Q4 2020 and 22 closed out, a net change of -13 holders.
  • The largest Acorda Therapeutics buyer in Q4 2020 was Renaissance Technologies, an estimated $190K added.
  • The largest Acorda Therapeutics seller in Q4 2020 was Point72 Asset Management, an estimated $840K sold.

Based on aggregated 13F filings for Q4 2020.